Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Drug Discovery: Overview01:26

Drug Discovery: Overview

11.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.8K
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

234
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
234
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

518
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
518
Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

1.4K
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
1.4K
Tumor Progression02:07

Tumor Progression

7.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids01:31

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids

709
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
709

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

The second Cryptosporidium meeting: Edinburgh's parasite deep dive.

Trends in parasitology·2026
Same author

Structure-Guided Optimization of Novel Inhibitors of <i>Plasmodium</i> Lysyl-tRNA Synthetase with Multistage Activity against Malaria Parasites.

Journal of medicinal chemistry·2026
Same author

Trypanosoma cruzi cell atlas as a single-cell resource for understanding parasite population heterogeneity and differentiation.

Nature communications·2026
Same author

FMOPhore for hotspot identification and efficient fragment-to-lead growth strategies.

Nature communications·2026
Same author

Use of a cytochrome P450 humanized mouse model to refine schistosomiasis drug discovery.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Experience from an HTS campaign: Investigation of susceptibility and rescue of SARS-CoV-2 nsp3 protease assay from metal contamination.

SLAS technology·2026

関連する実験動画

Updated: Feb 7, 2026

Competitive Homing Assays to Study Gut-tropic T Cell Migration
10:25

Competitive Homing Assays to Study Gut-tropic T Cell Migration

Published on: March 1, 2011

13.0K

熱帯病に対する薬の発見における課題と最近の進展

Manu De Rycker1, Beatriz Baragaña1, Suzanne L Duce2

  • 1Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.

Nature
|July 27, 2018
PubMed
まとめ

高い死亡率と経済的影響のために 熱帯感染症の新薬の開発は極めて重要です 現在の治療法は不十分で 効果的な治療法の研究と開発が急務です

さらに関連する動画

Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs
05:11

Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs

Published on: May 10, 2024

1.9K
Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
07:50

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Published on: July 16, 2012

14.8K

関連する実験動画

Last Updated: Feb 7, 2026

Competitive Homing Assays to Study Gut-tropic T Cell Migration
10:25

Competitive Homing Assays to Study Gut-tropic T Cell Migration

Published on: March 1, 2011

13.0K
Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs
05:11

Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs

Published on: May 10, 2024

1.9K
Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
07:50

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Published on: July 16, 2012

14.8K

科学分野:

  • 熱帯 医学
  • 感染症
  • 薬物開発

背景:

  • 感染性熱帯病は 深刻な死亡率や病率や経済的負担を 引き起こし,貧困層に不釣り合いな影響を及ぼします
  • 現存する医薬品の介入は これらの一般的な病気の多くには不十分です
  • これらの軽視された病気と闘うために 新種の治療薬が必要なのです

研究 の 目的:

  • 熱帯感染症の新薬開発に伴う課題を検討する.
  • この分野における最近の進歩を強調する.
  • 革新的な治療戦略の継続的な必要性を強調する

主な方法:

  • 熱帯病の治療における現在の研究開発に関する文献レビュー.
  • 薬の発見と臨床翻訳における障害の分析
  • この分野における最近の成功と残る障害をまとめます.

主要な成果:

  • 熱帯病の新薬の開発には大きな課題が残っている.
  • 最近は進展がみられたが,現在の能力と治療の必要性との間に大きなギャップが残っている.
  • 経済的負担と健康への影響は 継続的なイノベーションの緊急性を強調しています

結論:

  • 熱帯感染症の有効な治療法の開発は 顕著な成功にもかかわらず 複雑で長いプロセスです
  • 既存の課題を克服し,必要不可欠な治療法を提供するために,継続的な投資と研究が不可欠です.
  • 世界的な健康と経済への影響に対処するには 薬剤の発見と開発の継続的な努力が必要です